Cargando…
Relationship between changes in the 7-day urticaria activity score after treatment with omalizumab and the responsiveness of basophils to FcεRI stimulation in patients with chronic spontaneous urticaria
BACKGROUND: About one-half of all patients with chronic spontaneous urticaria have low or less reactivity of the basophils to FcεRI stimulation. However, the differences in the clinical characteristics between patients who show normal and attenuated basophil reactivities to FcεRI stimulation are sti...
Autores principales: | Endo, Takahiro, Toyoshima, Shota, Hayama, Koremasa, Tagui, Maho, Niwa, Yusuke, Ito, Mana, Terui, Tadashi, Okayama, Yoshimichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia Pacific Association of Allergy, Asthma and Clinical Immunology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203440/ https://www.ncbi.nlm.nih.gov/pubmed/32411577 http://dx.doi.org/10.5415/apallergy.2020.10.e12 |
Ejemplares similares
-
Response of FcεRI‐bearing leucocytes to omalizumab in chronic spontaneous urticaria
por: Alizadeh Aghdam, Mehran, et al.
Publicado: (2020) -
Elevated, FcεRI‐dependent MRGPRX2 expression on basophils in chronic urticaria
por: Bartko, Ewa A., et al.
Publicado: (2022) -
Successful treatment of intractable chronic spontaneous urticaria with omalizumab in a patient with ovarian cancer
por: Hayama, Koremasa, et al.
Publicado: (2021) -
Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin
por: Metz, Martin, et al.
Publicado: (2017) -
In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticaria
por: Moñino‐Romero, Sherezade, et al.
Publicado: (2023)